Skip Navigation

skip navigationNIDDK Home
NIDDK Reference Collection
Diet   Exercise   Health  
Home Page
-  

FAQ

Detailed Search

- -
NIDDK INFORMATION SERVICES
- -

Diabetes

Digestive Diseases

Endocrine and Metabolic Diseases

Hematologic Diseases

Kidney and Urologic Diseases

Weight-control Information Network

-
NIDDK EDUCATION
PROGRAMS

- -

National Diabetes Education Program

National Kidney Disease Education Program

-
- - -
NIDDK Home
-
Contact Us
-
New Search
-
Topic: diabetes (dm)
Title: GLP-1 Analogues.
Author: n/a
Source: IN: Clinical Impact of Incretin-Based Therapies on Type 2 Diabetes Management. Littleton, CO: Medical Education Resources. pp. 11-13.
Availability: Available from Medical Education Resources. 1500 W. Canal Court, Littleton, CO 80123. Website: www.mer.org. Price: Available free of charge.
Abstract: New research highlighting the role of incretin hormones in beta cell function, growth, and development shows potential to provide clinical benefit to patients and to expand the current treatment options for managing type 2 diabetes. This chapter on the glucagon-like peptide (GLP-1) analogues is from a monograph on the clinical impact of incretin-based therapies on the management of people with type 2 diabetes. The monograph is based on a continuing education symposium that was held in conjunction with the American Association of Diabetes Educators’ 2005 Annual Meeting. The authors describe the current research on exenatide, an incretin mimetic that has been shown to effectively lower blood glucose levels and improve glycosylated hemoglobin levels (a measure of blood glucose over time). Currently, exenatide is indicated for patients who are failing on metformin, sulfonylureas, or combination therapies. The chapter also mentions liraglutide, previously known as NN2211, which has a longer plasma half-life, enabling once-daily administration. The chapter includes a side bar summarizing the information that patients should know about exenatide injection. 2 figures. 1 table.

Format: Book Chapter
Language: English.
Major Keywords: Diabetes Mellitus. Type 2 Diabetes. Incretin Mimetics. Glucagon. Physiology. Patient Care Management. Hormones. Pancreas. Insulin. Drug Therapy. Exenatide.
Minor Keywords: Continuing Education. Hyperglycemia. Blood Glucose. Drug Effects. Administration and Dosage. Glycosylated Hemoglobin. Complications.
Publication Number: DMBK12298.
Printer-Friendly Version | Return to Search Results
<-- previous record | next record -->

View NIDDK Publications | NIDDK Health Information | Contact Us

The NIDDK Reference Collection is a service of the National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health.
NIDDK Clearinghouses Publications Catalog
5 Information Way
Bethesda, MD 20892–3568
Phone: 1–800–860–8747
TTY: 1–866–569–1162
Fax: 703–738–4929
Email: catalog@niddk.nih.gov

Privacy | Disclaimers | Accessibility | Public Use of Materials
H H S logo - link to U. S. Department of Health and Human Services NIH logo - link to the National Institute of Health NIDDK logo - link to the National Institute of Diabetes and Digestive and Kidney Diseases